Clinical Trial Update: Safety and Pharmacokinetics of VT-1598 [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic data for the antifungal VT-1598 in coccidioidomycosis have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coccidioidomycosis

Drugs mentioned

• VT-1598 (VT-1598)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Coccidioidomycosis | Phase 1 | Status: COMPLETED | Results posted: 2023-01-11